Affiliation:
1. Endocrinology and Nutrition, Hospital Central de Asturias, Oviedo, Spain
2. Endocrinology and Nutrition, Hospital Carlos Haya, Málaga, Spain
3. Medicine, Hospital San Agustín, Avilés, Spain
4. Clinical Biochemistry, Hospital Central de Asturias, Oviedo, Spain
Abstract
OBJECTIVE—The aim of this study was to define the incidence of type 2 diabetes in a low-risk Caucasian population in northern Spain and its association with various risk factors.
RESEARCH DESIGN AND METHODS—The Asturias Study is a prospective, population-based survey of diabetes and cardiovascular risk factors. The baseline examination was carried out during 1998–1999 when 1,034 individuals, aged 30–75 years, were randomly selected to determine the prevalence of type 2 diabetes and pre-diabetes in the Principality of Asturias (northern Spain). In 2004–2005, these same subjects were invited for a follow-up examination; 700 participated. This study includes only those individuals who did not have diabetes at baseline. We used the World Health Organization 1999 criteria to classify glucose metabolism at both baseline and follow-up.
RESULTS—The incidence of diabetes adjusted for the age and sex structure of Asturias was 10.8 cases/1,000 person-years (95% CI 8.1–14.8). The incidence rates were 5 cases/1,000 person-years in individuals with normoglycemia, 21 cases/1,000 person-years in individuals with isolated impaired glucose tolerance (IGT), 34.7 cases/1,000 person-years in individuals with isolated impaired fasting glucose (IFG), and 95.2 cases/1,000 person-years in individuals with combined IFG-IGT. Stepwise multiple logistic regression analysis showed that, together with fasting plasma glucose (FPG) and 2-h plasma glucose, which were the strongest predictors of diabetes, triglycerides and BMI were also independently associated with progression to diabetes.
CONCLUSIONS—In this 6-year prospective population-based study, we found an incidence of type 2 diabetes of 10.8 cases/1,000 person-years. Both FPG and 2-h plasma glucose were strongly predictive of diabetes, and their effect was additive.
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference37 articles.
1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047–1053, 2004
2. Diabetes Atlas, 2nd ed. Brussels, International Diabetes Federation 2003
3. Franch Nadal J, Álvarez Torrices JC, Álvarez Guisasola F, Diego Domínguez F, Hernández Mejía R, Cueto Espinar A: Epidemiología de la diabetes mellitus en la provincia de León. Med Clin (Barc) 98: 607–611,1992 [in Spanish]
4. Bayo J, Sola C, García F, Latorre PM, Vázquez JA: Prevalencia de la diabetes mellitus no dependiente de la insulina en Lejona (Vizcaya). Med Clin (Barc) 101: 609–612, 1993 [in Spanish]
5. Muñiz J, Hervada J, Juane R, López-Rodríguez I, Castro-Beiras A: Prevalence of diabetes mellitus in the population aged 40–69 years in Galicia, northwest Spain. Diabetes Res Clin Pract 30:137–142, 1995